Roughly 1 in 8 women will be diagnosed with invasive breast cancer over their lifetimes, according to the American Cancer ...

A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I ...

Interleukin 2 (IL-2) is the only systemic treatment currently available that is capable of curing patients with metastatic renal cell cancer (RCC ... cures about 8% of patients.